DoseGear research brief
Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and amidation modifications.
N-Acetyl Semax Amidate
Enhanced Nootropic Peptide | Cognitive Enhancement & Neuroprotection
DoseGear research brief
Enhanced and stabilized version of Russian nootropic Semax with superior stability, extended half-life, and enhanced bioavailability through acetylation and amidation modifications.
Bypasses blood-brain barrier via olfactory nerves with direct brain access; enhances BDNF upregulation and hippocampal plasticity.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Acetylated and amidated Semax derivative.
Proposed cognitive and neuroprotective research based on parent-like neurotrophic signaling; direct validation is limited.
Not reported for this derivative.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
A Nootropic Adrenocorticotropin Analog 4-10 Semax: 15 Years Experience in Its Design and Study (Parent Compound)
Effects of Semax on the Default Mode Network of the Brain (Parent Compound)
The Efficacy of Semax in the Treatment of Patients at Different Stages of Ischemic Stroke (Parent Compound)
The Peptide Semax Affects the Expression of Genes Related to the Immune and Vascular Systems in Rat Brain Focal Ischemia (Parent Compound)
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.